Early period onset linked to increased diabetes risk

Reprogrammed cells could be used to treat diabetes (1)

Prolactin levels unaffected in transgender women on hormone therapy

04 May 2018

A study, published in Endocrine Practice, reports that prolactin levels did not increase in transgender women on oestrogen plus spironolactone therapy.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read